However, the concentration of serum P1NP and 1,25-hydroxyvitamin increased slightly while the concentration of serum β-CTX decreased in the beraprost-treated group, indicating the potential of beraprost in the treatment of osteoporosis (Fig. 1L). This evidence concerns the gene CYP27A1 and osteoporosis.